Trufexo MT 10mg/120mg Capsule
By Trufexo MT
Rx
10 Capsule in a Strip

Composition
Montelukast(10mg) + Fexofenadine(120mg)

Manufacturer - Biotic Healthcare
Level 1, SCO 25, Swastik Vihar, India, Mansa Devi Complex, Panchkula, Haryana 134114

Expires on or after
October, 2025

liver
Trufexo MT 10mg/120mg Capsule is considered safe for individuals with liver disease, based on the available data. There is limited information indicating that adjusting the dosage of Trufexo MT 10mg/120mg Capsule may not be necessary for patients with liver issues. It is advised to consult your healthcare provider for further guidance on the use of this medication in relation to liver conditions.

kidney
Trufexo MT 10mg/120mg Capsule requires caution in kidney disease. Adjustments to the dose may be necessary. Consult your doctor as it can cause drowsiness in end-stage kidney disease.

alcohol
Caution is recommended when drinking alcohol while taking Trufexo MT 10mg/120mg Capsule. Consult your doctor for guidance.

driving
When taking Trufexo MT 10mg/120mg Capsule, it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Trufexo MT 10mg/120mg Capsule may not be safe to use during pregnancy. Limited human studies show potential harm to the baby. Animal studies indicate negative effects on fetal development. Your doctor will evaluate benefits and risks before prescribing. Consult your doctor.

breastfeeding
Trufexo MT 10mg/120mg Capsule is likely safe for breastfeeding, based on limited human data indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹145
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025